Category: Corporate NewsBy Rameda Adminسبتمبر 9, 2024 Author: Rameda Admin Post navigationPreviousPrevious post:Rameda Announces Price Increase Approvals for All Its Top ProductsNextNext post:Rameda Completes Largest Acquisition to DateRelated Postsأول صفقات راميدا في 2025 إضافة استراتيجية لمحفظة أدوية الأمراض المزمنةيوليو 7, 2025إفصاح توزيع أرباح قياسيةيوليو 7, 2025Rameda One-Pager 1Q25مايو 13, 2025Rameda Completes Largest Acquisition to Dateسبتمبر 30, 2024Rameda Announces Price Increase Approvals for All Its Top Productsأغسطس 7, 2024Rameda Expands Freely Priced Portfolio with Launch of Ramelact, Egypt’s First Lactase Enzyme Supplement for the treatment of Lactose Intoleranceمايو 28, 2024
Rameda Expands Freely Priced Portfolio with Launch of Ramelact, Egypt’s First Lactase Enzyme Supplement for the treatment of Lactose Intoleranceمايو 28, 2024
